Free for CRN members / $299 for non-members
Discover how non-animal methods and emerging NAMs are transforming ingredient safety assessment in this two-part CRN webinar series.
Animal testing has long been the foundation of safety assessments, but its limitations—and growing consumer scrutiny—are driving change. At the same time, scientific advances are transforming how toxicologists evaluate dietary supplement ingredient safety without relying on animal data.
This two-part CRN webinar series will equip attendees with the knowledge needed to navigate this shift. Experts will explain how established non-animal methods, such as threshold of toxicological concern (TTC) and read-across, have supported safety decisions and where their limitations remain. The program will then explore emerging non-animal methods (NAMs), including Omics technologies, in silico models, and AI-enabled tools that are reshaping modern toxicology.
With:
- Fred Lozy, Ph.D., Scientific Consultant II, Safety and Regulatory Affairs, Intertek Assuris
- Connie Mitchell, MS, Senior Scientific Program Manager, HESI Global
- Adam Wood, Scientist - Human Safety, Unilever
- A representative from ToxStrategies, a BlueRidge Life Sciences Company
Free for CRN members / $299 for non-members
